Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive ...
The Punch on MSN
Consistency, sacrifice played major roles in my academic excellence – Landmark first-class graduate
Daniella Abolarin, a Landmark University first-class graduate, shares her journey from a 2:2 to achieving academic excellence ...
IGV on MSN
Flying economy class for the first time
Gen Z is defiantly 'giving up' on ever owning a home and is spending more than saving, working less, and making risky ...
Live Science on MSN
Study Shows The Life Of Pantolambda's Were Larger Than Most Mammals
Pantolambda bathmodon, a stocky, now-extinct mammal, lived 62 million years ago and reached roughly 92 lbs in adulthood, which was a much larger size than most mammals that came before. Video credit: ...
Researchers caution that while the findings are promising, the observational study does not prove that GLP-1 drugs prevent ...
Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...
The elimination half-life of ASC50 after a single oral dose was 43, 89, 91, 87, 104, and 85 hours for 10 mg, 30 mg, 100 mg, 200 mg, 400 mg, and 600 mg, respectively, supporting once-daily or ...
Celcuity Inc. soared on best-in-class Phase 3 breast cancer data. Click to see why I have a Buy rating on CELC due to data, ...
Novo Nordisk wins FDA approval for Wegovy in a pill, introducing first oral GLP-1 option for obesity
After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making ...
4dOpinion
When school is also home: A Brown student, originally from Korea, finds comfort after a nightmare
If my first lecture at Brown taught me how literature embodies love,” the student writes, “the past few days at Brown have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback